5 master-"https:"-"https:"-"https:"-"https:"-"Univ" positions at Center for Biologics Evaluation and Research (CBER)

FDA Focus Towards More Efficient Factor VIII Drug Products to Improve the Treatment of Hemophilia A

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 9 days ago

: The mechanisms of blood coagulation and respective in vitro assays modeling this process. The mechanisms of FVIII plasma clearance and master respective protein interaction assays modeling relevant processes in

FDA Research Opportunity - Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 10 hours ago

manufacturing of CRISPR/Cas9-edited hematopoietic stem cell (HSC) therapeutics. Under the mentorship of the Principal Investigator, you will gain experience in cutting-edge genome editing techniques applied

FDA Research Opportunity - Dengue Neutralization Assay

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 10 hours ago

at the FDA’s White Oak campus in Silver Spring, Maryland and is part of the CBER research program, which includes more than 70 principal investigators. These investigators, whom the fellow will learn from and

FDA Fellowship - Development and Evaluation of Gene Therapy for Rare Neuromuscular and Neurological Diseases

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 13 days ago

is Dwi U. Kemaladewi (Dwi.kemaladewi@fda.hhs.gov ), Ph.D., Principal Investigator and Senior Staff Fellow at CBER. If you have questions about the nature of the research, please contact the mentor

FDA Research Opportunity in Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 13 days ago

manufacturing of CRISPR/Cas9-edited hematopoietic stem cell (HSC) therapeutics. Under the mentorship of the Principal Investigator, you will gain experience in cutting-edge genome editing techniques applied